ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.
'Markush structure search and enumeration is becoming of critical importance for structure IP and patent development,' said Alex Drijver, CEO of ChemAxon. 'It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.'
